Evaluation of anxiety and depression symptoms in patients undergoing initial oncology treatment: A clinical study

Abstract

Background: This clinical study aimed to evaluate the symptoms and severity of anxiety and depression among patients undergoing initial treatment in an oncology setup. The research focused on assessing the psychological and demographic factors related to anxiety and depression. Aims and Objectives: The aim of the study was to identify the symptoms and severity of anxiety and depression in patients admitted for the first time to an oncology setup. The specific objectives were to determine the psychological antecedents, i.e., severity and symptoms of anxiety and depression, and explore the differences in demographic antecedents, particularly gender. Methods: A total sample of 137 patients (69 males and 68 females) admitted for the first time to an oncology setup was included in the study. The data were collected using the Hospital Anxiety and Depression Scale (HADS), the Hamilton Anxiety Rating Scale (HAM-A), and the Patient Health Questionnaire-9 (PHQ-9). Purposive sampling technique was employed to recruit the participants. Results: Data analysis revealed the presence of symptoms of anxiety and depression among the participants, with varying severities. The results indicated that females exhibited higher levels of anxiety compared to males, while males showed higher levels of depression than females. Conclusion: This study provides evidence of the prevalence of anxiety and depression symptoms among patients undergoing initial oncology treatment. The findings highlight the importance of early identification and appropriate management of anxiety and depression in this patient population. Furthermore, the study demonstrates the gender differences in the levels of anxiety and depression, emphasizing the need for tailored interventions and support for both male and female patients.